ARIDIS PHARMACEUTICALS INC (ARDS) Forecast, Price Target & Analyst Ratings

NASDAQ:ARDS • US0403341045

Current stock price

0.3101 USD
+0.05 (+17.91%)
At close:
0.2619 USD
-0.05 (-15.54%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARIDIS PHARMACEUTICALS INC (ARDS).

Forecast Snapshot

Consensus Price Target

Price Target
$10.20
+ 3,189.26% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 14, 2023
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$10.20
Upside
+ 3,189.26%
From current price of $0.31 to mean target of $10.20, Based on 8 analyst forecasts
Low
$10.10
Median
$10.20
High
$10.50

Price Target Revisions

1 Month
66.67%
3 Months
66.67%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ARDS. The average price target is 10.2 USD. This implies a price increase of 3189.26% is expected in the next year compared to the current price of 0.3101.
The average price target has been revised upward by 66.67% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ARDS Current Analyst RatingARDS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ARDS Historical Analyst RatingsARDS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
ARDS was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ARDS.
In the previous month the buy percentage consensus was at a similar level.
ARDS was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-11-06HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-20HC Wainwright & Co.Maintains Buy -> Buy
2023-01-26HC Wainwright & Co.Maintains Buy
2022-08-16Maxim GroupDowngrade Buy -> Hold
2021-07-20HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 14, 2023

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
ARDS revenue by date.ARDS revenue by date.
1M
-1.96%		1.54M
54.00%		3.091M
100.71%		38.25M
1,137.46%		42.24M
10.43%		77.44M
83.33%		132.77M
71.45%		201.47M
51.74%		257.63M
27.88%
EBITDA
YoY % growth
ARDS ebitda by date.ARDS ebitda by date.
-22.06M
23.27%		-42.27M
-91.61%		-29.506M
30.20%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ARDS ebit by date.ARDS ebit by date.
-22.4M
23.00%		-42.71M
-90.67%		-29.993M
29.78%		-11.511M
61.62%		7.485M
165.02%		40.379M
439.47%		96.61M
139.26%		164.59M
70.37%		220.01M
33.67%
Operating Margin
ARDS operating margin by date.ARDS operating margin by date.
-2,240.00%-2,773.38%-970.33%-30.09%17.72%52.14%72.76%81.69%85.40%
EPS
YoY % growth
ARDS eps by date.ARDS eps by date.
-2.44
30.68%		-4.18
-71.31%		-1.96
53.11%		-0.55
71.90%		0.27
148.15%		1.50
465.38%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ARDS Yearly Revenue VS EstimatesARDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
ARDS Yearly EPS VS EstimatesARDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 -5 -10 -15 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
40.36%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
225.86%
Revenue Next 5 Year
145.96%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ARIDIS PHARMACEUTICALS INC / ARDS Forecast FAQ

What is the average price target for ARIDIS PHARMACEUTICALS INC (ARDS) stock?

8 analysts have analysed ARDS and the average price target is 10.2 USD. This implies a price increase of 3189.26% is expected in the next year compared to the current price of 0.3101.

What is the next earnings date for ARDS stock?

ARIDIS PHARMACEUTICALS INC (ARDS) will report earnings on 2023-08-14, after the market close.

How many analysts have analysed ARIDIS PHARMACEUTICALS INC (ARDS)?

The number of analysts covering ARIDIS PHARMACEUTICALS INC (ARDS) is 8.